NASDAQ : FORA
Forian Inc. — Key statistics
Healthcare · Health Information Services · United States
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 67.79M |
| Enterprise Value | 36.85M |
Dates
| Measure | Value |
|---|
| Earnings Date | Jun 2, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 31.24M |
| Shares Outstanding | 31.24M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 54.97% |
| Owned by Institutions (%) | 17.24% |
| Float | 11.56M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.26 |
| Forward PS | 2.07 |
| PB Ratio | 2.52 |
| P/TBV Ratio | 2.61 |
| P/FCF Ratio | 35.86 |
| P/OCF Ratio | 35.86 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 19.49 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.14 |
| Quick Ratio | 2.92 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.00 |
| Interest Coverage | -65.25 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -17.95% |
| Return on Assets (ROA) | -8.37% |
| Return on Invested Capital (ROIC) | -11.48% |
| Return on Capital Employed (ROCE) | -21.76% |
| Weighted Average Cost of Capital (WACC) | 9.46% |
| Revenue Per Employee | $601,038 |
| Profits Per Employee | -$102,206 |
| Employee Count | 50 |
| Asset Turnover | 0.69 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 250,525 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.93 |
| 52-Week Price Change | +6.90% |
| 50-Day Moving Average | 2.12 |
| 200-Day Moving Average | 2.12 |
| Relative Strength Index (RSI) | 63.99 |
| Average Volume (20 Days) | 49,650 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 53,578 |
| Short Previous Month | 50,599 |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.46% |
| Short Ratio (days to cover) | 1.41 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 30.05M |
| Gross Profit | 14.18M |
| Operating Income | -5.85M |
| Pretax Income | -4.86M |
| Net Income | -5.11M |
| EBITDA | -5.64M |
| EBIT | -5.85M |
| Loss Per Share | -$0.16 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 30.95M |
| Total Debt | 6,104 |
| Net Cash | 30.95M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 26.89M |
| Book Value Per Share | 0.86 |
| Working Capital | 25.48M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.89M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 208,505 |
| Net Borrowing | -6.84M |
| Free Cash Flow | 1.89M |
| FCF Per Share | $0.06 |
Margins
| Measure | Value |
|---|
| Gross Margin | 47.19% |
| Operating Margin | -19.47% |
| Pretax Margin | -16.17% |
| Profit Margin | -17.00% |
| EBITDA Margin | -18.78% |
| EBIT Margin | -19.47% |
| FCF Margin | 6.29% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | -0.06% |
| Earnings Yield | -7.54% |
| FCF Yield | 2.79% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |